Framycetin

From Wikipedia, the free encyclopedia

Framycetin
Systematic (IUPAC) name
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)
-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)
-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)
-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy
-5-(hydroxymethyl)oxolan-2-yl]oxy
-3-hydroxycyclohexyl]oxyoxane-3,4-diol
Identifiers
CAS number  ?
ATC code R01AX08
PubChem 8378
Chemical data
Formula C23H46N6O13 
Mol. mass 614.644 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes oral, topical

Framycetin is an antibiotic of the aminoglycoside class similar to neomycin. Like neomycin, it has poor systemic absorption. It is used in topical preparations for infections of the skin, nose, ears, and eyes, often in combination with other antibacterial drugs and corticosteroids. It can also be used for gastrointestinal infections.

Framycetin is commonly sold as Soframycin and Sofra-Tulle.

Languages